← Back to patent-cliff list

Enitociclib

Tier C — Watch / trade

Enitociclib

Bayer
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type

Targets:CDK9, PTEFb

Indications (approved):Non-Hodgkin lymphoma, Lymphoma, Haematological malignancy, Neoplasm, 里氏综合征, Chronic lymphocytic leukaemia

Regional status

US
Phase II
2023-04-05
EU
Discontinued
2016-02-10
China
-
Japan
-

Synthetic routes & intermediates1 routes

Originator routes × 1Optimised (non-patent) × 0Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 4 · Total yield 50 mg (BAY-1251152)
BAY-12511521610358-53-6BAY-1251152-001179899-07-1BAY-1251152-002884494-49-9BAY-1251152-0031602486-03-2BAY-1251152-004179554-98-4BAY-1251152-0051602486-04-3BAY-1251152-006354-38-1BAY-1251152-0071610359-06-2API · Enitociclib
CodeCAS No.Intermediate
BAY-12511521610358-53-6((2-((5-fluoro-4-(4-fluoro-2-methoxyphenyl)pyridin-2-yl)amino)pyridin-4-yl)methyl)(imino)(methyl)-l6-sulfanone
BAY-1251152-001179899-07-1(4-fluoro-2-methoxyphenyl)boronic acid
BAY-1251152-002884494-49-92-chloro-5-fluoro-4-iodopyridine
BAY-1251152-0031602486-03-22-chloro-5-fluoro-4-(4-fluoro-2-methoxyphenyl)pyridine
BAY-1251152-004179554-98-44-((methylthio)methyl)pyridin-2-amine
BAY-1251152-0051602486-04-35-fluoro-4-(4-fluoro-2-methoxyphenyl)-N-(4-((methylthio)methyl)pyridin-2-yl)pyridin-2-amine
BAY-1251152-006354-38-12,2,2-trifluoroacetamide
BAY-1251152-0071610359-06-2(E)-2,2,2-trifluoro-N-(((2-((5-fluoro-4-(4-fluoro-2-methoxyphenyl)pyridin-2-yl)amino)pyridin-4-yl)methyl)(methyl)-l4-sulfaneylidene)acetamide

Frequently asked questions

What are the approved indications of Enitociclib?

Approved indications include: Non-Hodgkin lymphoma, Lymphoma, Haematological malignancy, Neoplasm, 里氏综合征, Chronic lymphocytic leukaemia.

When does the Enitociclib patent expire?

No public expiry year is available for Enitociclib yet; this page updates once verified.

How many synthesis routes are recorded for Enitociclib?

1 synthesis routes are recorded; the shortest is 4 steps with 50 mg (BAY-1251152) total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Enitociclib intermediates?

All intermediates in Enitociclib routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.

How do I get a quote for Enitociclib intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-10-22